Talk with a health care professional about what to expect after surgery. Your health care professional may prescribe medicines to relax your bladder muscles and prevent spasms. After surgery, the prostate, urethra, and surrounding areas may be irritated and swollen. You may need surgery to remove part or all of your prostate if These minimally invasive surgical therapies (MIST) remove enlarged prostate tissue or widen the urethra so urine flows more easily. Tell a health care professional about any side effects you have while taking medicines to treat BPH. Prompt diagnosis and treatment of prostate cancer greatly improves outlook. Benign prostatic hyperplasia (BPH) is a condition in which the prostate gland grows larger than normal, but the growth is not caused by cancer. It’s essential to note that BPH is not a sign of prostate cancer, and having BPH does not increase your risk of developing prostate cancer. One theory is that, as you age, the amount of testosterone in your body decreases (low testosterone). When BPH causes your prostate to grow, it can cause blockage in your urethra. About half of all people with BPH will develop symptoms that require treatment. By age 60, about 50% of people with a prostate will have some signs of BPH. BPH is the most common prostate problem among males. Your healthcare provider will review your medical history, ask you questions and perform a physical examination. A urologist is a doctor who specializes in treating conditions that affect your urinary system. If your healthcare provider suspects you have BPH, they may refer you to a urologist. According to this idea, once the prostate has enough testosterone or DHT to work, adding more doesn’t have a stronger effect. The increase is usually not enough to cause new urinary symptoms or make existing symptoms worse. It attaches to receptors in prostate cells and can stimulate growth. DHT is much more active in the prostate than testosterone. But in adult men, the prostate does not rely heavily on testosterone to keep working. This idea started over 75 years ago, when doctors found that lowering testosterone in men with prostate cancer helped slow the disease. Many people think that higher testosterone levels can cause prostate cancer. Working with a doctor to monitor symptoms can keep both testosterone levels and prostate health in balance. They may also make cuts in the prostate to widen the urethra to relieve blockages. A healthcare professional may suggest that a person with BPH undergoes surgery if medications and other treatments do not work. Some widen the urethra, which can help relieve blockages and urinary retention. As they age, the amount of testosterone in their blood decreases, leaving a higher proportion of estrogen. It drives prostate growth and is a primary driver of BPH. This refers to a prostate that is enlarged but not cancerous. An enlarged prostate is one symptom of prostate cancer. Studies suggest BPH may occur because the increased estrogen levels in the prostate increase the activity of substances that promote prostate cell growth. This article discusses the symptoms of an enlarged prostate, potential causes, treatment, prevention, and when to speak with a doctor. The most common prostate issue in people over 50 years old is benign prostatic hyperplasia (BPH). Those who have low blood PSA levels at diagnosis, and whose tumors have a low Gleason grade and less-advanced clinical stage tend to have better prognoses. Around 80% of prostate cancer diagnoses are in men whose cancer is still confined to the prostate. As those severely ill with metastatic prostate cancer approach the end of their lives, most experience confusion and may hallucinate or have trouble recognizing loved ones. People with prostate cancer are around twice as likely to experience anxiety or depression compared to those without cancer. General weakness can also be caused by anemia, itself caused by a combination of the disease itself, poor nutrition, and damage to the bone marrow from cancer treatments or bone metastases. Metastases compress the spinal cord in up to 12% of those with metastatic prostate cancer causing pain, weakness, numbness, and paralysis. Those whose tumors have defective DNA damage repair benefit from treatment with the immune checkpoint inhibitor drug pembrolizumab and PARP inhibitors, namely olaparib, rucaparib, or niraparib.
